Hualan Biological Engineering’s vaccine performance declined in 2011H1, blood product business expected to be favorable

Search by Type

Report Charts News

Search by Company

Code Company name

Hualan Biological Engineering’s vaccine performance declined in 2011H1, blood product business expected to be favorable

Date:2011-09-05 Source:hangmeihangmei Text Size:

On 16 Aug. 2011, Hualan Biological released its semi-annual report, according to which, its operating revenue reached RMB470 million, a decline of 23.6% YoY; meanwhile, its net profit achieved RMB2...

Welcome to our website. This service is open to member only.

Registration

Contact our customer service team
Tel: 86-10-82600828, 82600893
Fax: 86-10-82601570
Email: report@researchinchina.com

Related Reports

China Heparin Industry Report, 2010-20112011-09-28
China Blood Products Industry Report, 2010-20112011-09-05
China Monoclonal Antibody Industry Report, 2010-20112011-07-05
China Insulin Industry Report, 20102011-01-25
China Heparin Industry Report, 20102010-12-18
China Blood Products Industry Report, 20102010-11-10
Global and China Biopharmaceutical Industry Report, 20102010-09-16
China Blood Products Industry Report, 20092009-10-13